Chemopreventive effects of orange peel extract (OPE) II. OPE inhibits atypical hyperplastic lesions in rodent mammary gland

Journal of Medicinal Food

Volumn 10, Issue 1, 2007, Pages 18-24

  Abe, Sadanori ^a   Fan, Kunhua ^a   Ho, Chi Tang ^b   Ghai, Geetha ^b   Yang, Kan ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Chemoprevention; Mammary gland; Polymethyoxyflavones

Indexed keywords

CITRUS FRUIT EXTRACT; FLAVONE DERIVATIVE; NOBILETIN; ORANGE PEEL EXTRACT; SINENSITIN; TANGERELIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST HYPERPLASIA; CANCER INHIBITION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; DISEASE COURSE; DRUG EFFECT; DRUG INHIBITION; DRUG MIXTURE; FEEDING; FEMALE; MAMMARY GLAND; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TUMOR GROWTH;

MUS; RODENTIA;

EID: 34248160425     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2006.0215     Document Type: Article

References (44)

1. Ingram DM: Trends in diets and breast cancer mortality in England and Wales. 1928-1977. Nutr Cancer 1981;3:75-80.
2. Armstrong B, Doll R: Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975;15:617-631.
3. Carroll KK: Experimental evidence of dietary factors and hormone-dependent cancers. Cancer Res 1975;35:3374-3383.
4. Cohen LA, Thompson DO, Maeura Y, Choi K, Blank ME, Rose DP: Dietary fat and mammary cancer. 1. Promoting effects of different dietary fats on N-nitrosomethylurea-induced rat mammary tumorigenesis. J Natl Cancer Inst 1986;77:33-42.
5. Weisch CW, House JL, Herr BL, Eliasberg SJ, Welsch MA: Enhancement of mammary carcinogenesis by high levels of dietary fat: a phenomenon dependent on ad libitum feeding. J Natl Cancer Inst 1990;82:1615-1620.
6. Abraham S, Faulkin LJ, Hillyard LA, Mitchell DJ: Effect of dietary fat on tumorigenesis in the mouse mammary gland. J Natl Cancer Inst 1984;72:1421-1429.
7. Welsch CW: Enhancement of mammary tumorigenesis by dietary fat: review of potential mechanisms. Am J Clin Nutr 1987;45: 192-202.
8. Winters BL, Mitchell DC, Smiciklas-Wright H, Grosvenor MB, Liu W, Blackburn GL: Dietary patterns in women treated for breast cancer who successfully reduce fat intake: the Women's Intervention Nutrition Study (WINS). J Am Diet Assoc 2004;104: 551-559.
9. Carroll KK, Eckel LA, Fraher LJ, Frei JV, Newmark HL: Dietary calcium, phosphate and vitamin D in relation to mammary carcinogenesis. In: Calcium, Vitamin D and Prevention of Colon Cancer (Lipkin M, Newmark HL, Kelloff G, eds.), CRC Press, Boca Raton, FL, 1991, pp. 229-239.
10. Jacobson EA, James KA, Newmark HL, Carroll KK: Effects of dietary, fat, calcium, and vitamin D on growth and mammary tumorigenesis induced by 7,12 dimethylbenz-a-anthracene in female Sprague-Dawley rats. Cancer Res 1989;49:6300-6303.
11. Khan N, Yang K, Newmark H, et al.: Mammary duct epithelial cell hyperproliferation and hyperplasia induced by a nutritional stress diet containing four components of a Western-style diet. Carcinogenesis 1994;15:2645-2648.
12. Xue L, Newmark H, Yang K, Lipkin M: Model of mouse mammary gland hyperproliferation and hyperplasia induced by a Western-style diet. Nutr Cancer 1996;26,281-287.
13. Newmark HL, Yang K, Lipkin M, et al.: A Western-style diet induces benign and malignant neoplasms in the colon of normal C57B1/6 mice. Carcinogenesis 2001;22:1871-1875.
14. Chen J, Montanari A, Wilbur W, Widmer WW: Two new polymethoxylated flavones, a class of compounds with potential anticancer activity, isolated from cold pressed Dancy tangerine peel oil solids. J Agric Food Chem 1997;45:364-368.
15. Manthey JA, Grohmann K, Guthrie N: Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr Med Chem 2001;8:135-153.
16. Delaney B, Phillips KK, Buswell D, et al.: Immunotoxicity of a standardized citrus polymethoxylated flavone extract. Food Chem Toxicol 2001;39:1087-1094.
17. Manthey JA, Guthrie N: Antiproliferative activities of citrus flavonoids against six human cancer cell lines. J Agric Food Chem 2002;50:5837-5843.
18. Kawaii S, Tomono Y, Katase E, Ogawa K, Yano M: Antiproliferative activity of flavonoids on several cancer cell lines. Biosci Biotechnol Biochem 1999;63:896-899.
19. Tanaka T, Makita H, Kawabata K, et al.: Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis 1997;18:957-965.
20. Middleton E Jr, Kandaswami C, Theoharides TC: The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000; 52:673-751.
21. Whitman SC, Kurowska EM, Manthey JA, Daugherty A: Nobiletin, a citrus flavonoid isolated from tangerines, selectively inhibits class A scavenger receptor-mediated metabolism of acetylated LDL by mouse macrophages. Atherosclerosis 2005;178: 25-32.
22. So FV, Guthrie N, Chambers AF, Mussa M, Carroll KK: Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer 1996;26:167-181.
23. Guthrie N, Carroll KK: Inhibition of mammary cancer by citrus flavonoids. Adv Exp Med Biol 1998;439:227-236.
24. Bracke ME, Depypere HT, Boterberg T, et al.: Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer. J Natl Cancer Inst 1999;91:354-359.
25. Chappidi C: Absorption and metabolism of citrus polymethoxyflavones [M.S. Thesis], Rutgers University, New Brunswick, NJ, 2005.
26. Min/+ mice. J Med Food 2007;10: 11-17.
27. Takshashi T, Kobori M, Shinmoto H, Tushida T: Structure-activity relationships of flavonoids and the induction of granulocytic- or monocytic-differentiation in HL60 human myeloid leukemia cells. Biosci Biotechnol Biochem 1998;62:2199-2204.
28. Tanaka T, Makita H, Kawabata K, et al.: Modulation of N-methyl-N-amylnitrosamine-induced rat oesophageal tumourigenesis by dietary feeding of diosmin and hesperidin, both alone and in combination. Carcinogenesis 1997;18:761-769.
29. Yang M, Tanaka T, Hirose Y, Deguchi T, Mori H, Kawada Y: Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice. Int J Cancer 1997;73:719-724.
30. Wellings SR, Jensen HM, Marcum RG: An atlas of subgross pathology of human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 1975;55:231-273.
31. Kandaswami C, Perkins E, Soloniuk DS, Drzewiecki G, Middleton E Jr: Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. Cancer Lett 1991;56:147-152.
32. Kawaii S, Tomono Y, Katase E, Ogawa K, Yano M: HL-60 differentiating activity and flavonoid content of the readily extractable fraction prepared from citrus juices. J Agric Food Chem 1999;47:128-135.
33. Miyazawa M, Okuno Y, Fukuyama M, Nakamura S, Kosaka H: Antimutagenic activity of polymethoxyflavonoids from Citrus aurantium. J Agric Food Chem 1999;47:5239-5244.
34. Breinholt V, Lauridsen ST, Dragsted LO: Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat. Xenobiotica 1999;29:1227-1240.
35. Obermeier MT, White RE, Yang CS: Effects of bioflavonoids on hepatic P450 activities. Xenobiotica 1995;25:575-584.
36. Siess MH, Ledere J, Canivenc-Lavier MC, Rat P, Suschetet M: Heterogenous effects of natural flavonoids on monooxygenase activities in human and rat liver microsomes. Toxicol Appl Pharmacol 1995;130:73-78.
37. Malterud KE, Rydland KM: Inhibitors of 15-lipoxygenase from orange peel. J Agric Food Chem 2000;48:5576-5580.
38. Chaumontet C, Bex V, Gaillard-Sanchez I, Seillan-Heberden C, Suschetet M, Martel P: Apigenin and tangeretin enhance gap junctional intercellular communication in rat liver epithelial cells. Carcinogenesis 1994;15:2325-2330.
39. Pan MH, Chen WJ, Lin-Shiau SY, Ho CT, Lin JK: Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis 2002;23:1677-1684.
40. Sato T, Koike L, Miyata Y, et al.: Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma HT-1080 cells. Cancer Res 2002;62:1025-1029.
41. Yoshimizu N, Otani Y, Saikawa Y, et al.: Anti-tumor effects of nobiletin, a citrus flavonoid, on gastric cancer include: antiproliferative effects, induction of apoptosis and cell cycle deregulation. Aliment Pharmacol Ther 2004;20(Suppl 1):95-101.
42. Kohno H, Yoshitani S, Tsukio Y, et al.: Dietary administration of citrus nobiletin inhibits azoxymethane-induced colonic aberrant crypt foci in rats. Life Sci 2001;69:901-913.
43. Murakami A, Nakamura Y, Torikai K, et al.: Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res 2000; 60:5059-5066.
44. Moon YJ, Wang X, Morries ME: Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro 2006;20: 187-210.